Hip labral tear: surgery or just therapy? new study aims to settle the debate
NCT ID NCT03909178
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two treatments for a torn hip labrum in people aged 40 and older: arthroscopic surgery to repair the tear versus physical therapy alone. Researchers want to find out which approach leads to better hip function and less pain. The goal is to help doctors and patients decide when surgery is truly needed and when conservative care may be enough.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Hip arthroscopy surgery with labral repair
- What this could lead to
- If this trial succeeds, it could show that physical therapy is as good as surgery for many older patients, helping avoid unnecessary operations.
- What could go wrong
- This is a relatively small trial (110 people) and results may not apply to everyone. Also, some patients may still need surgery later if therapy fails.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACETABULAR LABRUM TEAR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
MGH, Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Bone-Sparing hip implant outperform traditional replacement?
- Which hip implant lasts longer? a Head-to-Head trial aims to find out
- Which stitch heals hips better? a trial seeks answers
- Can a new hip implant stand the test of time?
- Virtual reality workouts could rebuild strength in MS patients
- Hormone therapy may thaw frozen shoulders faster — a trial puts it to the test